Table:
begin	end	state
1	5	non-cytoplasmic
6	25	transmembrane
26	31	cytoplasmic
32	54	transmembrane
55	60	non-cytoplasmic
61	83	transmembrane
84	103	non-cytoplasmic
104	133	transmembrane
134	142	cytoplasmic
143	161	transmembrane
162	180	non-cytoplasmic
181	201	transmembrane
202	233	cytoplasmic
234	257	transmembrane
258	270	non-cytoplasmic
271	293	transmembrane
294	307	cytoplasmic
308	330	transmembrane
331	337	non-cytoplasmic
338	362	transmembrane
363	366	cytoplasmic
367	390	transmembrane
391	395	non-cytoplasmic
396	419	transmembrane
420	430	cytoplasmic
431	453	transmembrane
454	456	non-cytoplasmic

Input:
>BPHYT_RS13375
MATVQGSLLLVYALIAIIALVVLIARFKMNPFITLMVVSVALALAVGMPATSILKSFETG
VGGTLGHIAIVVGLGTMLGKMMAESGGAERIARTLIDLFGPKNVHWAMMCIAFLVGLPVF
FEVGFVLLIPIAFNVAQRTGTSMIRVGIPMVAGLSVVHGLIPPHPAALLAVTAYNADIGH
TIFYALIVGIPTAAIAGPLFSKLIARFVVLDGVNPMAQQFIEQDAKRSHQELPGFGITLL
TVLLPVLLMLVGSWADLIVPAKSTANNVLRLIGHPDMALLLAVLLSFITFGKARGFNRDQ
ILKFTNECLAPTASITLVVGAGAGFGRILIDSGASKAIVDVATGAHVPLLILAWLVAALI
RVATGSATVAMATAAGIIAPIAAAAASTVGGVRPELLVLATGAGSLILSHVNDGGFWLVK
EYFGMTVPQTFKTWTVCETIISVTALLLTLGLSTVI

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server